Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 13:14:1384244.
doi: 10.3389/fcimb.2024.1384244. eCollection 2024.

Editorial: Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning

Taís Fontoura de Almeida  1 , Edézio Ferreira Cunha-Junior  2 , João Luiz Mendes Wanderley  3 , Juliana da Silva Pacheco  4 , Lucia Helena Pinto-da-Silva  5 , Valter Viana Andrade-Neto  6 , Suzana Passos Chaves  3
Affiliations
Editorial

Editorial: Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning

Taís Fontoura de Almeida et al. Front Cell Infect Microbiol. .
No abstract available

Keywords: Leishmania; chemotherapy; flavonoid; immunomodulation; nanoparticles; protozoa; repositioning drugs; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning

References

    1. Andrade-Neto V. V., Cunha-Junior E. F., Dos Santos Faioes V., Pereira T. M., Silva R. L., Leon L. L., et al. . (2018). Leishmaniasis treatment: update of possibilities for drug repurposing. Front. Biosci. (Landmark Ed). 23 (5), 967–996. doi: 10.2741/4629 - DOI - PubMed
    1. Burza S., Croft S. L., Boelaert M. (2018). Leishmaniasis. Lancet 392, 951–970. doi: 10.1016/S0140-6736(18)31204-2 - DOI - PubMed
    1. Ruiz-Postigo J. A., Jain S., Maia-Elkhoury A. M. A. N., Valadas S., Warusavithana S., Osman M., et al. . (2021). Global leishmaniasis surveillance: 2019-2020, a baseline for the 2030 roadmap/Surveillance mondiale de la leishmaniose: 2019-2020, une periode de reference pour la feuille de route a l’horizon 2030. Weekly Epidemiological Record. 96, 401–420.
    1. Gervazoni L. F. O., Barcellos G. B., Ferreira-Paes T., et al. . (2020). Use of natural products in Leishmaniasis 128 chemotherapy: an overview. Front. Chem. 8. doi: 10.3389/fchem.2020.579891 (Accessed 8 February 2024). - DOI - PMC - PubMed

Publication types

MeSH terms